Zydus settles patent litigation with Kowa
Shital Jibhe / 17 Jan 2017
Cadila Healthcare Ltd, a global pharmaceutical company and its subsidiary Zydus Pharmaceuticals, has announced settlement of all outstanding patent litigations related to Livalo (Pitavastatin Calcium) tablets with Kowa Company Limited, Kowa Pharmaceuticals America and Nissan Chemical Industries Ltd.
Cadila Healthcare Ltd, a global pharmaceutical company and its subsidiary Zydus Pharmaceuticals, has announced settlement of all outstanding patent litigations related to Livalo (Pitavastatin Calcium) tablets with Kowa Company Limited, Kowa Pharmaceuticals America and Nissan Chemical Industries Ltd.
As per the settlement, Kowa and Nissan will grant licence to market Zydus’ generic version of Livalo beginning May 2, 2023, or earlier.
Zydus Cadila is a global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. Cadila Healthcare Ltd is an India-based pharmaceutical company.
The company's subsidiaries include Zydus Wellness Limited, Liva Pharmaceuticals Limited, Biochem Pharmaceutical Industries Limited, Zydus Technologies Limited, German Remedies Limited, Dialforhealth India Limited, Dialforhealth Unity Limited and Dialforhealth Greencross Limited, among others.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.